Overcoming chemotherapy resistance with herbal medicines: Past, present and future perspectives

Phytochemistry Reviews

Volumn 13, Issue 1, 2014, Pages 323-337

  Wang, Zhijun ^a   Xie, Chen ^b   Huang, Ying ^a   Lam, Christopher Wai Kei ^b   Chow, Moses S S ^a,b  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b China Macau University of Science and Technology Zhuhai MUST Science and Technology Research Institute   (Macao)

Author keywords

Chemosensitizing agent; Chemotherapy; Chinese medicine; Drug resistance; Herbal medicine

Indexed keywords

6 ([1,3]DIOXOLO[4,5 G]ISOQUINOLINE 5 CARBONYL) 2,3 DIMETHOXYBENZOIC ACID METHYL ESTER; 8 OXOCOPTISINE; ANDROGRAPHOLIDE; ANTINEOPLASTIC AGENT; APIGENIN; BERBERINE; CAMPTOTHECIN; CEPHARANTHINE; CISPLATIN; CURCUMIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; FISETIN; FLUOROURACIL; GINSENOSIDE RG 3; GINSENOSIDE RH 2; HERBACEOUS AGENT; HONOKIOL; LUTEOLIN; MYRICETIN; PACLITAXEL; PALMATINE; PARTHENOLIDE; QUERCETIN; TETRAMETHYLPYRAZINE; THEANINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SENSITIZATION; HERBAL MEDICINE; HUMAN; IC 50; LEUKEMIA; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL;

EID: 84894639794     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-013-9327-z     Document Type: Article

References (61)

1. Al Sawah E, Marchion D, Xiong Y, Ramirez-Diaz I, Abbasi F, Bou Zgheib N, Hakam A, Wenham R, Lancaster J, Judson Lancaster P (2013) Molecular characterization of polyphyllin D, a Chinese herb that sensitizes ovarian cancers cells to platinum therapy. Gynecol Oncol 130:e131-e132
2. Angelini A, Di Ilio C, Castellani ML, Conti P, Cuccurullo F (2010) Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicinresistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. J Biol Regul Homeost Agents 24:197-205
3. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul Pn (2002) Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64:573-582
4. Arienti C, Tesei A, Ravaioli A, Ratta M, Carloni S, Mangianti S, Ulivi P, Nicoletti S, Amadori D, ZoliW(2008) Activity of lipoplatin in tumor and in normal cells in vitro. Anticancer Drugs 19(983-990):9. doi:10.1097/CAD. 1090b1013e3283114fb3283112
5. Baumert C, Hilgeroth A (2009) Recent advances in the development of P-gp inhibitors. Anti-Cancer Agents Med Chem 9:415-436
6. Chauvier D, Kegelaer G, Morjani H, ManfaitM(2002) Reversal of multidrug resistance-associated protein-mediated daunorubicin resistance by camptothecin. J Pharm Sci 91:1765-1775 (Pubitemid 34810522)
7. Che CT, Wang ZJ, Chow MS, Lam CW, 2013 Herb-herb combination for therapeutic enhancement and advancement: theory, practice and future perspectives. Molecules (Basel, Switzerland) 18, 5125-5141
8. Chen YW, Lin GJ, Chuang YP, Chia WT, Hueng DY, Lin CK, Nieh S, Sytwu HK (2010) Triptolide circumvents drugresistant effect and enhances 5-fluorouracil antitumor effect on KB cells. Anticancer Drugs 21:502-513
9. Chou T-C (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621-681
10. Chow MSS, Huang Y, Wang JJH, Ravula R, Wang Z, (2014). Use of extraction products from tripterygium wilfordii to overcome chemotherapy resistance, PCT/US13/55602 patent to be published in March 2014
11. Ciolino HP, Clarke R, Yeh GC, Plouzek CA (1999) Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer 35:1541-1545 (Pubitemid 29454653)
12. Crea F, Duhagon MA, Farrar WL, Danesi R (2011) Pharmacogenomics and cancer stem cells: a changing landscape? Trends Pharmacol Sci 32:487-494
13. Domingo-Domenech J, Vida lSamuel J, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal Dennis M, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, Petrylak Daniel P, Benson Mitchell C, Silva Jose M, Cordon-Cardo C (2012) Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell 22:373-388
14. Fleming JB, Brekken RA (2003) Functional imaging of angiogenesis in an orthotopic model of pancreatic cancer. J Cell Biochem 90:492-501 (Pubitemid 37243696)
15. Han Y, Bu LM, Ji X, Liu CY, Wang ZH (2005) Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line. Chin J Dig Dis 6:82-86 (Pubitemid 40936490)
16. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M, Inouye Y, Kasai R, Yamasaki K (1995) Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med 61:409-413
17. He C, Rong R, Liu J, Wan J, Zhou K, Kang J (2012) Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells. Chin Med 7:11
18. Huang Y, Blower PE, Yang C, Barbacioru C, Dai Z, Zhang Y, Xiao JJ, Chan KK, Sadee W (2005) Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1. Pharmacogenomics J 5:112-125 (Pubitemid 40468118)
19. Huang M, Jin J, Sun H, Liu G (2008) Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae. Cancer Chemother Pharmacol 62:1015-1026
20. Huang CY, Chen JY, Wu JE, Pu YS, Liu GY, Pan MH, Huang YT, Huang AM, Hwang CC, Chung SJ, Hour TC (2010) Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells. J Agric Food Chem 58:8798-8805
21. Jayakumar T, Hsieh CY, Lee JJ, Sheu JR (2013) Experimental and clinical pharmacology of andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid Based Complement Alternat Med 2013:846740
22. Kim S (2009) Animal models of cancer in the head and neck region. Clin Exp Otorhinolaryngol 2:55-60
23. Kim S-W, Kwon H-y, Chi D-W, Shim J-H, Park J-D, Lee Y-H, Pyo S, Rhee DK (2003) Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3. Biochem Pharmacol 65:75-82 (Pubitemid 35447841)
24. Li W, TangY, Chen Y, Duan JA, 2012. Advances in the chemical analysis and biological activities of chuanxiong. molecules (Basel, Switzerland) 17, 10614-10651
25. Liu X, Meng S, Yang J (1997) Reversal effect of R3 (Extract from a Chinese herb Bu-Gu-Zhi) on MDR of MCF7adr cell line. Chin J Clin Oncol 24:325-330
26. Longley DB, Johnston PG (2005) Molecular mechanisms of drug resistance. J Pathol 205:275-292 (Pubitemid 40227997)
27. Makarovskiy AN, Siryaporn E, Hixson DC, Akerley W (2002) Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure. Cellular and molecular life sciences: CMLS 59:1198-1211
28. Merchant AA, Matsui W (2010) Targeting Hedgehog-a cancer stem cell pathway. Clin Cancer Res 16:3130-3140
29. Min Y, Yang M, Lee K, Kim K, Choi S, Lee K (2006) Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica Makino. Arch Pharm Res 29:757-761
30. Núñez Sellés AJ, Vélez Castro HT, Agüero-Agüero J, González-González J, Naddeo F, De Simone F, Rastrelli L (2002) Isolation and quantitative analysis of phenolic antioxidants, free sugars, and polyols from mango (mangifera indica l.) stem bark aqueous decoction used in cuba as a nutritional supplement. J Agri Food Chem 50:762-766 (Pubitemid 34163620)
31. Richmond A, Su Y (2008) Mouse xenograft models vs GEM models for human cancer therapeutics. Dis mod mech 1:78-82
32. Robey RW, Massey PR, Amiri-Kordestani L, Bates SE (2010) ABC transporters: unvalidated therapeutic targets in cancer and the CNS. Anti-Cancer Agents Med Chem 10:625-633
33. Sadasivan S, Latha PG, Sasikumar JM, Rajashekaran S, Shyamal S, Shine VJ (2006) Hepatoprotective studies on Hedyotis corymbosa (L.) Lam. J Ethnopharmacol 106:245-249 (Pubitemid 43766194)
34. Sadzuka Y, Sugiyama T, Sonobe T (2000) Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance. Toxicol Lett 114:155-162 (Pubitemid 30125452)
35. Salzberg M, Rochlitz C, Morant R, Thalmann G, Pedrazzini A, Roggero E, Schonenberger A, Knuth A, Borner M (2007) An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer. Onkologie 30:355-360 (Pubitemid 47013371)
36. Sano M, Takahashi Y, Yoshino K, Shimoi K, Nakamura Y, Tomita I, Oguni I, Konomoto H (1995) Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding. Biol Pharm Bull 18:1006-1008
37. Shen P, Xia L, Zhang HJ (2005) Discovery of the main active constituents of siwu mixture for reversing the multidrug resistance of human erythrocyte leukemic cell line K562/ADM. Chin J Chin materia medica 30:520-523
38. Shu P, Liu SS (2008) Clinical observation on reversal effects of multi-drug resistance gene and lung resistance protein in gastric cancer treated by Shenqi Jian wei decoction. Hunan, J Trad Chin med, pp 1-3
39. Singh A, Wu H, Zhang P, Happel C, Ma J, Biswal S (2010) Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype. Mol Cancer Ther 9:2365-2376
40. Sirotnak FM, Zakowski MF, Miller VA, Scher HI, Kris MG (2000) Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin Cancer Res 6:4885-4892 (Pubitemid 32110433)
41. Sui H, Liu X, Jin BH, Pan SF, Zhou LH, Yu NA, Wu J, Cai JF, Fan ZZ, Zhu HR, Li Q (2013) Zuo Jin Wan, a traditional chinese herbal formula, reverses p-gp-mediated mdr in vitro and in vivo. Evid Based Complement Alternat Med 2013:957078
42. Sun X, Sun J (2009) The first effect of Yi Qi Yang Yin Fang on reversing multidrug resistance of the human lung adenocarcinoma A549DDp cell line. J.Prac Oncol 23:26-28
43. Takara K, Horibe S, Obata Y, Yoshikawa E, Ohnishi N, Yokoyama T (2005) Effects of 19 Herbal Extracts on the Sensitivity to Paclitaxel or 5-Fluorouracil in HeLa Cells. Biol Pharmaceutical Bulletin 28:138-142 (Pubitemid 40879798)
44. Tian QE, De Li H, Yan M, Cai HL, Tan QY, Zhang WY (2012) Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro. BMC Complement Altern Med 12:94
45. van Zanden JJ, de Mul A, Wortelboer HM, Usta M, van Bladeren PJ, Rietjens IMCM, Cnubben NHP (2005) Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin. Biochem Pharmacol 69:1657-1665 (Pubitemid 40719501)
46. Wang P, Jin X, Qi M, Fang L (2004) Liquid chromatography-mass spectrometry method for determination of tetramethylpyrazine and its metabolite in dog plasma. J Chromatogr B 813:263-268 (Pubitemid 39535455)
47. Wang J, Xia Y, Wang H, Hou Z (2007) Chinese herbs of shenghe powder reverse multidrug resistance of gastric carcinoma SGC-7901. Integr Cancer Ther 6:400-404
48. Wang ZJ, Wo SK, Wang L, Lau CBS, Lee VHL, Chow MSS, Zuo Z (2009) Simultaneous quantification of active components in the herbs and products of Si-Wu-Tang by high performance liquid chromatography-mass spectrometry. J Pharm Biomed Anal 50:232-244
49. Wang XB, Wang SS, Zhang QF, Liu M, Li HL, Liu Y, Wang JN, Zheng F, Guo LY, Xiang JZ (2010a) Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells. Oncol Rep 23:211-215
50. Wang Z, Ravula R, Cao M, Chow M, Huang Y (2010b) Transporter-mediated multidrug resistance and its modulation by Chinese medicines and other herbal products. Curr Drug Discov Technol 7:54-66
51. Wang Z, Lau B, Ravula R, Huang Y, Chow MSS, (2011) An improved method for evaluation of chemosensitzing effect from herb-drug combination-Example with Tripteryguim Wilfordii. Abstract of 8th Int Conf of Society of Integrative Oncology, Cleveland, Ohio, Nov 10-12
52. Wang Z, Yeung S, Tran T, Huang Y, Chow MSS (2012) A new approach for quantifying chemosensitizing effect from herb-drug combination: assessment of Tripterygium Wilfordii-Docetaxel in prostate cancer. Abstract of integrative medicine & health: strengthening research in integrative healthcare around the world 2012 annual meeting, Portland, OR, May 15-18
53. Xia Y, Li Y, Wang J, Wang H, Kang J, Wang B, Hou Z (2011) Bidirectional function of shenghe powder on repair of radiation-induced DNA damage in glioma and astrocyte. Afr J Tradit Complement Altern Med 8:196-206
54. Xiao H, Xiao Q, Zhang K, Zuo X, Shrestha U (2010) Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R. Ann Hematol 89:399-404
55. Xin Y, Yin F, Qi S, Shen L, Xu Y, Luo L, Lan L, Yin Z (2013) Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation. Toxicol Lett 221:73-82
56. Xu D, Tian W, Shen H (2011) Curcumin prevents induced drug resistance: a novel function? Chin J Cancer Res 23:218-223
57. Xu T, Sun X, Ren D, Yang G (2012) Anti-proliferation activity of luteolin and its role in combined chemotherapy on lung cancer A549 cells. J Shangdong University (Health Sciences) 50:5
58. Xu M, Zhu XH, Sheng LH (2008) Effect of supplement energy and nourish lung herbs on drug-resistance lung cancer with mechanisms of mitochondrial and caspase signal. Zhong Yao Cai 31:1396-1399
59. Yuan H, Li X, Wu J, Li J, Qu X, Xu W, Tang W (2008) Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance. Curr Med Chem 15:470-476 (Pubitemid 351472413)
60. Zhan X, Zhang R, Xu y, Yang S, Xie D, Tan L (2012) Empirical studies about quercetin increasing chemosensitivity on human lung adenocarcinoma cell line A549. Chin Ger J Clin Oncol 11:4
61. Zhou Y, Hopper-Borge E, Shen T, Huang X-C, Shi Z, Kuang Y-H, Furukawa T, Akiyama Si, Peng XX, Ashby CR Jr, Chen X, Kruh GD, Chen ZS (2009) Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance. Biochem Pharmacol 77:993-1001